Robert E Schoen

Title: The Innovations of Robert E Schoen

Introduction

Robert E Schoen is a notable inventor based in Pittsburgh, PA, who has made significant contributions to the field of medical research. With a total of three patents to his name, his work primarily focuses on advancements in cancer diagnosis and treatment.

Latest Patents

One of his latest patents is titled "Anti-mucin 1 binding agents and uses thereof." This disclosure provides anti-MUC1 binding agents, such as antibodies and chimeric antigen receptors, along with methods for treatment, prophylaxis, detection, and diagnosis using these agents. Another significant patent is "Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof." This patent discusses proteins useful in diagnosing proliferative disorders of the colon, characterized by molecular weight, isoelectric point, and amino acid sequence. These proteins can be identified through techniques like 2D-gel electrophoresis or by specific binding partners, such as antibodies.

Career Highlights

Robert E Schoen has had a distinguished career, working with esteemed institutions such as the University of Pittsburgh and Bluefin Biomedicine, Inc. His research has contributed to the understanding and treatment of various cancers, particularly colon cancer.

Collaborations

Throughout his career, Schoen has collaborated with notable colleagues, including Gisela Bruenagel and Robert H Getzenberg. These collaborations have further enhanced the impact of his research in the medical field.

Conclusion

Robert E Schoen's innovative work in cancer research and his patented inventions highlight his significant contributions to medical science. His dedication to improving diagnosis and treatment options continues to influence the field positively.